You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Biliary tract cancer

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Biliary Tract Cancer Trial in Shanghai (Capecitabine combined with lenvatinib and tislelizumab)

Recruiting
  • Biliary Tract Cancer
  • Capecitabine combined with lenvatinib and tislelizumab
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 23, 2022

Borderline Resectable Carcinoma, Biliary Tract Cancer Trial in Washington (Durvalumab, Tremelimumab, Gemcitabine)

Not yet recruiting
  • Borderline Resectable Carcinoma
  • Biliary Tract Cancer
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center, Georgetown University
Aug 24, 2023

Biliary Tract Cancer Trial in Seoul ('SMT-NK' Inj (allogeneic Natural Killer cell), Pembrolizumab Injection [Keytruda])

Completed
  • Biliary Tract Cancer
  • 'SMT-NK' Inj (allogeneic Natural Killer cell)
  • Pembrolizumab Injection [Keytruda]
  • Seoul, Korea, Republic of
  • +1 more
Mar 28, 2022

Carcinoma, Hepatocellular, Biliary Tract Cancer, Secondary Liver Cancer Trial in Worldwide (RO7119929, Tocilizumab)

Completed
  • Carcinoma, Hepatocellular
  • +3 more
  • Duarte, California
  • +9 more
Jan 27, 2023

Malignant Ascites Trial in Taichung (Nivolumab, Pembrolizumab)

Enrolling by invitation
  • Malignant Ascites
  • Taichung, Please Select, Taiwan
    China Medical University Hospital
Feb 16, 2023

ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

Recruiting
  • ARID1A Gene Mutation
  • +15 more
  • Scottsdale, Arizona
  • +4 more
Dec 13, 2022

Adult Soft Tissue Sarcoma, Non Small Cell Lung Cancer, Triple Negative Breast Cancer Trial in France (Ezabenlimab + BI907828)

Not yet recruiting
  • Adult Soft Tissue Sarcoma
  • +4 more
  • Ezabenlimab + BI907828
  • Bordeaux, France
  • +5 more
Oct 19, 2023

Pancreatic Cancer, Biliary Tract Cancer Trial in Beijing (Durvalumab, Lenvatinib, Nab paclitaxel)

Recruiting
  • Pancreatic Cancer
  • Biliary Tract Cancer
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinese PLA General Hospital
Apr 7, 2022

Biliary Tract Cancer Trial in Xuzhou (Surufatinib Toripalimab)

Recruiting
  • Biliary Tract Cancer
  • Surufatinib Toripalimab
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Dec 22, 2021

Advanced Biliary Tract Carcinoma Trial in Hangzhou (Camrelizumab, apatinib, gemcitabine, oxaliplatin, tegafur)

Not yet recruiting
  • Advanced Biliary Tract Carcinoma
  • Camrelizumab, apatinib, gemcitabine, oxaliplatin, tegafur
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, School of Medicine, Zhejiang Univ
Jul 6, 2022

Biliary Tract Cancer Trial in Philadelphia (XmAb20717)

Recruiting
  • Biliary Tract Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center at University of Pennsylvania
Apr 11, 2022

Biliary Tract Tumors Trial (TST001)

Not yet recruiting
  • Biliary Tract Neoplasms
  • (no location specified)
Dec 28, 2021

Pancreas Cancer, Biliary Tract Cancer, Psychological Distress Trial (Psilocybin)

Not yet recruiting
  • Pancreas Cancer
  • +2 more
  • (no location specified)
Oct 31, 2022

Biliary Tract Adenocarcinoma Trial in Shanghai (HAIC, Gemcitabine, Oxaliplatin)

Enrolling by invitation
  • Biliary Tract Adenocarcinoma
  • HAIC
  • +4 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
May 27, 2022

Biliary Tract Cancer, Cholangiocarcinoma Trial in Italy (Gemcitabine, Nab paclitaxel, Cisplatin)

Not yet recruiting
  • Biliary Tract Cancer
  • Cholangiocarcinoma
  • Ancona, Italy
  • +18 more
Sep 16, 2023

Patients With Cholangiocarcinoma and Gallbladder Cancer

Recruiting
  • Biliary Tract Cancer
  • +2 more
    • Herlev, Copenhagen, Denmark
      Herlev & Gentofte Hospital
    Dec 21, 2021

    Pancreatic Cancer Trial in Baltimore (Gemcitabine, Cisplatin, Pembrolizumab)

    Not yet recruiting
    • Pancreatic Cancer
    • Baltimore, Maryland
      SKCCC Johns Hopkins
    Aug 16, 2023

    Predict the Response of Biliary Tract Tumors to Immunotherapy

    Recruiting
    • Biliary Tract Tumor
    • Cholangiocarcinoma
    • Blood samples, tumor biopsy specimens will be collected
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Sep 22, 2023

    Biliary Tract Cancer Trial in Shanghai (ZKAB001 5mg/kg, Capecitabine)

    Enrolling by invitation
    • Biliary Tract Cancer
    • Shanghai, China
      Renji Hospital Affiliated to School of Medicine, Shanghai Jiaoto
    Jan 10, 2022

    Biliary Tract Cancer (BTC) Trial in Taiwan (next-generation sequencing)

    Recruiting
    • Biliary Tract Cancer (BTC)
    • next-generation sequencing
    • Chiayi City, Taiwan
    • +12 more
    Jun 12, 2022

    Biliary Carcinoma Trial in China (TQB3454 tablets, TQB3454 tablets matching )

    Not yet recruiting
    • Biliary Carcinoma
    • TQB3454 tablets
    • TQB3454 tablets matching placebo
    • Beijing, Beijing, China
    • +5 more
    Aug 4, 2023

    Gemcitabine, Biliary Tract Cancer, Immune Checkpoint Inhibitors Trial in Hangzhou (Gemcitabine-based chemo regimen combined with

    Not yet recruiting
    • Gemcitabine
    • +2 more
    • Gemcitabine-based chemotherapy regimen combined with immunocheckpoint inhibitors
    • Hangzhou, Zhejiang, China
      Hangzhou First People's Hospital
    Aug 2, 2022

    Intrahepatic Cholangiocarcinoma Trial in Germany (Durvalumab, Tremelimumab)

    Recruiting
    • Intrahepatic Cholangiocarcinoma
    • Dresden, Germany
    • +7 more
    Apr 13, 2022

    Biliary Tract Cancer, PD-1 Antibody, Gemox Trial in Shanghai (PD-1+Lenvatinib+GEMOX)

    Recruiting
    • Biliary Tract Cancer
    • +3 more
    • Shanghai, China
      Zhongshan hospital
    Dec 11, 2021

    Biliary Tract Tumors Trial in Seoul (Durvalumab, Tremelimumab, Gemcitabine)

    Active, not recruiting
    • Biliary Tract Neoplasms
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Oct 26, 2021